Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Address Pharmacy Recommendation

Johnstown, Pennsylvania Survey Completed on 12-12-2024

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to respond in a timely manner to a pharmacy recommendation for a resident. A quarterly Minimum Data Set (MDS) assessment for a resident, dated November 3, 2024, indicated that the resident was cognitively intact, required assistance for daily care needs, received routine and as-needed pain medication, and had a diagnosis of diabetes. A pharmacy Medication Regimen Review (MRR) recommendation, dated July 7, 2024, suggested that the physician consider ordering Senna, a stimulant laxative, once daily at bedtime while monitoring for signs and symptoms of constipation. However, there was no documented evidence that the physician reviewed or addressed this recommendation. An interview with the Director of Nursing on December 12, 2024, confirmed the lack of documented evidence that the physician addressed the pharmacy MRR for the resident, which should have been done according to the facility's policies and procedures.

Plan Of Correction

1. Physician to review medication recommendation with resident. 2. A baseline audit was completed for pharmacy recommendations. 3. The Director of Nursing/designee will educate nursing staff including agency on the process of following through with pharmacy recommendations. 4. To maintain and monitor compliance, a weekly audit will be conducted by the Director of Nursing or designee for four weeks, then monthly for two months to ensure follow through of pharmacy recommendations. Results of this audit will be reviewed by the Quality Assurance and Improvement Committee for additional recommendations if necessary.

An unhandled error has occurred. Reload 🗙